Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
JSK Biomed logo — Pioneering the future of anti-aging with innovative needle-f...

JSK Biomed

Pioneering the future of anti-aging with innovative needle-free transdermal drug delivery technology.

Founded 2015 Series A Total: $1.20B Health Care, Medical Devices

General Information

Company Name JSK Biomed
Founded Year 2015
Industries Health Care, Medical Devices
Funding Stage Series A
Social

Get notified when JSK Biomed moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About JSK Biomed

JSK Biomed is a pioneering company that focuses on the research and development of bio-medical devices, with a primary focus on anti-aging solutions. Their flagship product, Mirage Jet, is a revolutionary needle-free injector that redefines the transdermal drug delivery landscape. This innovative technology offers a safe and effective solution for anti-aging treatments without the use of needles. Moreover, JSK Biomed is committed to the advancement of bio-equipment and the progression of transdermal drug delivery systems. With its establishment in 2015, the company operates within the Health Care and Medical Devices industries. In June 2020, the company secured a substantial KRW1.20B Series A investment from Kudos Ventures, marking a significant milestone in its development and growth trajectory.

Taxonomy: biomedical devices, transdermal drug delivery, needle-free injector, anti-aging treatments, innovative technology, bio-medical research, advanced equipment, drug delivery systems

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
03 Jun 2020
Non Equity Assistance •••••• 1 •••• •••• 01 Oct 2019

JSK Biomed Alternatives & Competitors

JSK Biomed vs
Corium International
Corium International

Harnessing proprietary technologies to advance transdermal drug delivery for enhanced therapeutic ou...

Debt Financing
201-500 employees
Biotechnology, Health Care
JSK Biomed vs
TransPharma Medical
TransPharma Medical

Pioneering transdermal drug delivery to enhance therapeutic outcomes for osteoporosis and other pept...

Series C
Biotechnology, Health Care
JSK Biomed vs
ARx, LLC
ARx, LLC United States

Patient-friendly, alternative drug delivery systems through Oral Thin Films and Transdermal Patches.

55 employees
Health Care, Manufacturing

FAQ About JSK Biomed

Pioneering the future of anti-aging with innovative needle-free transdermal drug delivery technology.
JSK Biomed was founded in 2015.
JSK Biomed operates in the following industries: Health Care, Medical Devices.
JSK Biomed has completed 2 funding rounds, raising a total of $1.20B. The latest funding stage is Series A.
Top alternatives and competitors to JSK Biomed include Corium International, TransPharma Medical, ARx, LLC, Bionex Pharmaceuticals LLC, Zosano Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
JSK Biomed and Corium International are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors JSK Biomed and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes